Examiner: CARCANAGUE, DANIEL R

Tech Center 1600 • Art Units: 1621 1625

This examiner grants 81% of resolved cases

Performance Statistics

80.8%

Allow Rate

+20.8% vs TC avg

932

Total Applications

+24.5%

Interview Lift

616

Avg Prosecution Days

Based on 930 resolved cases, 2023–2026

1.7%

§101 Eligibility

18.4%

§102 Novelty

25.0%

§103 Obviousness

34.5%

§112 Clarity

App #	Title	Status	Assignee
18746981	PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS	Non-Final OA	Xenon Pharmaceuticals Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.